Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2691 |
Oritavancin diphosphate
奥利万星二磷酸盐,LY333328 diphosphate |
Others; Antibacterial; Antibiotic | Microbiology/Virology; Others |
Oritavancin diphosphate (LY333328 diphosphate) 是一种新型半合成的糖肽抗生素, 可研究革兰氏阳性菌感染。 | |||
T37881 | Oritavancin(LY-333328) | ||
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. |